Technical problems derailed Japan’s coronavirus vaccination booking system on Wednesday, compounding frustration over the government’s handling of new outbreaks of infections and an inoculation drive that critics say has been woefully slow.
Étiqueté : Reuters
Eighteen people have died from the COVID-19 respiratory disease outside of hospitals in Japan’s Osaka Prefecture, officials said, amid calls for tougher restrictions on movement to halt a fourth wave of infections ahead of the Olympics.
Japanese business leaders and a Nobel-prizewinning biologist called upon the government to reform its vaccination programme, including allowing drive-through inoculations, as the nation struggles to contain a resurgence of the COVID-19 pandemic.
Highly infectious strain of coronavirus first identified in the U.K. — N501Y — now accounts for a third of new infections
Prime Minister Yoshihide Suga on Friday approved stricter measures to stamp out soaring coronavirus cases for Tokyo, Okinawa and Kyoto — effective Monday — as variants pose a fresh threat to a public already frazzled by monthslong restrictions.
Surveys show wide interest among county’s residents in being inoculated
South Korea launched its COVID-19 inoculation campaign on Friday, with shots to be administered in some 200 nursing homes, in an effort that officials call the first step in returning the country to more normal life.
Thailand will start vaccinating priority groups including health workers against COVID-19 by the end of this week, its prime minister said on Tuesday, a day ahead of the arrival of the country’s first coronavirus vaccines.
– In the city where the pathogen was first detected, shoppers make last-minute purchases for family celebrations
– It is a contrast with last year when hospitals overflowed with the sick and dying
– The technology, deployed as both a phone app and a physical device, is being used by nearly 80 per cent of the 5.7 million population
– Privacy concerns have been raised about such apps in various places, including Israel and South Korea.
[Chine] La Chine suspend l’arrivée des voyageurs en provenance du Royaume-Uni, à l’exception des ressortissants chinois
Selon une annonce faite jeudi le 3 novembre par l’ambassade et les consulats chinois au Royaume-Uni, la Chine a déclaré qu’elle suspendait temporairement, en raison de la pandémie de COVID-19, l’entrée des ressortissants britanniques sur son territoire, même si ces derniers sont détenteurs de visas ou de permis de séjours en Chine.
Japan’s largest airport opened a novel coronavirus testing facility Monday as it takes steps to reopen international travel that has been largely grounded for months by the pandemic. The Narita International Airport PCR Center is aimed at outbound travelers who need proof that they are virus-free when they arrive at their destinations.
PEKIN (Reuters) – L’un des potentiels vaccins développés en Chine contre le coronavirus s’est avéré sûr et a déclenché des réponses immunitaires lors des deux premières phases d’essais cliniques sur des volontaires humains, selon une étude publiée jeudi par la revue médicale The Lancet.
[Asie] Asean, China, Japan, South Korea financial leaders redouble efforts to focus on coronavirus recovery
– Finance ministers and central bank governors from the Asean+3 group said they will use all available policy tools to support a sustained recovery
– The Covid-19 pandemic has triggered deep downturns in regional economies, disrupted global trade and supply chains, and increased market volatility
TOKYO (Reuters) – Japanese researchers said on Wednesday that low concentrations of ozone can neutralise coronavirus particles, potentially providing a way for hospitals to disinfect examination rooms and waiting areas.
SEOUL (Reuters) — South Korean authorities reported the highest daily rise in novel coronavirus cases since early March on Sunday, saying tougher social distancing rules may be needed as outbreaks continued to spread from a Seoul church and other gatherings.
[Chine] China Sinopharm’s potential COVID-19 vaccine triggers antibodies in clinical trials: journal
BEIJING (Reuters) – A coronavirus vaccine candidate developed by a unit of China National Pharmaceutical Group (Sinopharm) appeared to be safe and triggered antibody-based immune responses in early and mid-stage trials, researchers said.